|
|
|
Insider
Information: |
Barabe Timothy C |
Relationship: |
Director |
City: |
Woburn |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
257,267 |
|
Indirect Shares
|
7,120 |
|
|
Direct
Value |
$1,740,536 |
|
|
Indirect Value
|
$142,400 |
|
|
Total
Shares |
264,387 |
|
|
Total
Value |
$1,882,936 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-100.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Arqule Inc |
ARQL |
Director |
2020-01-16 |
0 |
2005-03-04 |
7,120 |
Premium* |
|
Human Genome Sciences Inc |
HGSI |
Chief Financial Officer |
2010-02-22 |
49,570 |
2007-06-27 |
0 |
Premium* |
|
Affymetrix Inc |
AFFX |
Chief Financial Officer |
2013-03-18 |
166,378 |
|
0 |
Premium* |
|
Acer Therapeutics Inc |
ACER |
Director |
2016-11-18 |
12,910 |
2014-03-19 |
0 |
Premium* |
|
Veeva Systems Inc |
VEEV |
Director |
2021-06-22 |
6,643 |
2015-12-09 |
0 |
Premium* |
|
Cartesian Therapeutics, Inc |
RNAC |
Director |
2024-08-12 |
21,766 |
2017-03-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
253 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2007-06-27 |
4 |
B |
$9.00 |
$24,300 |
D/D |
2,700 |
2,700 |
2.74 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2007-06-28 |
4 |
B |
$9.10 |
$66,430 |
D/D |
7,300 |
10,000 |
2.74 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2007-07-11 |
4 |
B |
$7.59 |
$15,126 |
D/D |
1,993 |
11,993 |
2.74 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2008-03-07 |
4 |
B |
$5.14 |
$51,400 |
D/D |
10,000 |
21,993 |
2.74 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2008-07-01 |
4 |
B |
$4.49 |
$10,242 |
D/D |
2,281 |
24,274 |
2.74 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2008-11-13 |
4 |
B |
$2.00 |
$19,978 |
D/D |
10,000 |
34,274 |
2.74 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2008-11-14 |
4 |
B |
$1.99 |
$19,900 |
D/D |
10,000 |
44,274 |
2.74 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2009-06-30 |
4 |
B |
$1.80 |
$1,800 |
D/D |
1,000 |
45,274 |
2.66 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2009-11-20 |
4 |
OE |
$10.11 |
$299,994 |
D/D |
29,673 |
39,674 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2010-02-03 |
4 |
OE |
$0.52 |
$66,671 |
D/D |
28,329 |
68,003 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2010-02-03 |
4 |
AS |
$27.92 |
$639,481 |
D/D |
(22,907) |
45,096 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2010-02-10 |
4 |
OE |
$10.11 |
$45,242 |
D/D |
4,475 |
49,571 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2010-02-22 |
4 |
OE |
$4.92 |
$281,424 |
D/D |
57,200 |
106,771 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2010-02-22 |
4 |
AS |
$30.01 |
$1,716,315 |
D/D |
(57,200) |
49,571 |
0 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2010-03-18 |
4 |
A |
$7.50 |
$150,000 |
D/D |
20,000 |
35,000 |
0 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2010-04-27 |
4 |
B |
$6.45 |
$32,250 |
D/D |
5,000 |
40,000 |
2.74 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2010-05-07 |
4 |
B |
$6.00 |
$30,820 |
D/D |
5,000 |
45,000 |
2.74 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2010-07-27 |
4 |
B |
$4.50 |
$45,000 |
D/D |
10,000 |
55,000 |
2.74 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2010-08-19 |
4 |
A |
$4.22 |
$63,300 |
D/D |
15,000 |
70,000 |
0 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2010-08-20 |
4 |
B |
$4.09 |
$40,900 |
D/D |
10,000 |
80,000 |
2.74 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2010-11-19 |
4 |
B |
$4.29 |
$21,443 |
D/D |
5,000 |
85,000 |
2.74 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2011-02-17 |
4 |
A |
$5.31 |
$53,100 |
D/D |
10,000 |
95,000 |
0 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2011-03-18 |
4 |
D |
$4.60 |
$8,510 |
D/D |
(1,850) |
93,150 |
0 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2011-08-04 |
4 |
B |
$4.75 |
$47,500 |
D/D |
10,000 |
103,150 |
2.74 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2011-08-09 |
4 |
B |
$4.25 |
$42,500 |
D/D |
10,000 |
113,150 |
2.74 |
- |
|
253 Records found
|
|
Page 1 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|